Market Context — Why This Technology, Why Now

The global healthcare industry is rapidly shifting towards precision medicine and value-based care, demanding solutions that enhance patient safety and optimize resource allocation. Simultaneously, persistent healthcare labor shortages and increasing regulatory scrutiny on medication errors are driving urgent demand for automated, intelligent support systems. This technology offers a timely solution to these converging pressures, enabling providers to deliver higher quality care more efficiently.

Key Competitive Advantages
01

Supports individualized dosage decisions based on patient biometric data and past medication history, contributing to reduced side effect risks and maximized treatment efficacy.

02

Significantly reduces healthcare professional workload by eliminating the subjectivity of traditional manual judgments and providing objective dosage probabilities via AI. Healthcare professionals could reduce decision-making burden and focus more on patient care.

03

Continuously improves accuracy in clinical settings as the machine learning model continuously learns from physician dosage decision data as training input. This could consistently enhance practical decision accuracy.

Market Opportunity
Hospitals and Clinics
$1.0B globally (AI est.)
Reducing healthcare professional workload and minimizing medical errors are urgent challenges for hospital management. AI-powered dosage support directly enhances operational efficiency and medical safety.
Large hospital networks Regional clinic groups Healthcare IT providers
Home Healthcare and Community Care
$200M globally (AI est.)
As the importance of home healthcare grows in aging societies, there is a strong demand for improved accuracy and reduced burden in medication management for visiting nurses and caregivers.
Home care service providers Telemedicine platform developers Elderly care facility operators
Pharmaceutical Companies and CROs
$3.5B globally (AI est.)
This technology could provide value by optimizing dosages during clinical trials for new drug development and monitoring drug efficacy based on real-world data post-market launch.
Global pharmaceutical R&D divisions Contract Research Organizations (CROs) Health data analytics firms
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a broad scope of dosage management support systems, covering the input, calculation, and decision logic based on machine learning. Its strong claims and minimal prior art suggest high technical originality, making it a robust intellectual property that could effectively deter competitors and provide a long-term competitive advantage.

Competitive White Space

This patent focuses on the AI-driven decision logic for dosage management. It does not cover novel drug discovery, advanced patient monitoring hardware, or specific drug delivery mechanisms, offering white space for complementary IP development.

Economic Impact
~$130K–$330K/year estimated operational efficiency gain per facility (AI est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

This technology could reduce the time physicians and nurses spend on dosage decisions by approximately 20% annually. For example, assuming 100 healthcare professionals spend 1,000 hours annually on medication management, with an annual personnel cost of ~$67K (AI est.) per person, a 20% reduction could lead to an annual operational efficiency gain of ~$130K–$330K (AI est.) per facility.

Speed to Market
6× faster than in-house development
This technology's core machine learning algorithm and system architecture for dosage decision logic are already established and patented. This eliminates the need for licensees to conduct research and development from scratch, significantly reducing time spent on fundamental technology validation and algorithm establishment. Leveraging this patented foundation, licensees can focus on tuning the model with their own data and integrating with existing medical information systems, potentially accelerating market entry by approximately 2.5 years.
Competitive Positioning

X: Healthcare Professional Workload Reduction
Y: Dosage Decision Accuracy & Safety

Business Models & Applications
☁️ SaaS Service Provision
Provide this system as a cloud service, allowing healthcare institutions to access advanced dosage management support features via a monthly subscription, minimizing initial investment. This model ensures data integration and security, establishing a sustainable revenue stream.
🤝 Technology Licensing
License the core algorithm and system architecture of this technology to existing EHR system vendors and medical device manufacturers. This enables licensees to enhance the value of their products and strengthen market competitiveness.
🛠️ Co-development and Customization
Undertake customized development or joint R&D to meet the specific needs of particular healthcare institutions or pharmaceutical companies. This could involve building high-precision models for specific diseases or drugs, collaboratively creating new market opportunities.
Adjacent Application Opportunities
👵 Elderly Care & Monitoring
Medication Management for Seniors
This technology could be adapted to support medication timing and dosage management for seniors in care facilities or at home. By detecting risks of missed doses or over-medication based on vital data and behavioral patterns, it could notify caregivers and family, supporting safer living for an estimated 20% of the elderly population requiring assistance.
🏃 Sports & Wellness
Supplement Intake Optimization
Applicable as a system to recommend optimal supplement types and dosages for athletes and health-conscious individuals, based on body data (activity levels, sleep, diet records) and target goals. This could contribute to maximizing training effectiveness and maintaining health, potentially improving performance by 10-15%.
🐾 Veterinary Medicine
Pet Medication Management Support
Could be applied as a system to manage and support medication dosages and timing for pets, tailored to species, weight, and condition, for veterinary clinics and pet owners. This could reduce veterinarian workload by an estimated 15% and contribute to appropriate pet health maintenance.
Integration Roadmap — Estimated 17-Month Deployment
Phase 1: Requirements Definition and Basic Design
Duration: 4 months
Define integration requirements with the licensee's existing systems (EHR, diagnostic systems, etc.), and design data flow and security. Determine customization directions based on the core technology model to suit the deployment environment.
Phase 2: System Development and Pilot Testing
Duration: 9 months
Proceed with system development based on defined requirements, tuning and validating the machine learning model using the licensee's actual clinical data. Optimize functions and performance through pilot testing in a limited environment.
Phase 3: Production Deployment and Operational Optimization
Duration: 4 months
Deploy the system into the production environment based on insights from pilot testing, and provide training for healthcare professionals. Continuously monitor system performance post-deployment, aiming for long-term value maximization through model retraining and functional improvements based on operational data.
Technical Feasibility
This technology features a system architecture comprising an input unit and a calculation unit, designed for seamless data integration with existing electronic health record (EHR) systems and diagnostic equipment. The patent claims explicitly mention patient biomarker values and their changes as input data, indicating high compatibility with general-purpose sensors and existing diagnostic data. Since the machine learning model is generated using training data, it is technically feasible to build a high-accuracy system rapidly by leveraging physician decision data accumulated in the licensee's clinical environment.
Success Scenario
Upon implementing this technology, healthcare professionals could potentially reduce the time spent on dosage decisions by up to 20%. This would allow more time to be dedicated to patient care, leading to improved patient satisfaction and an overall elevation of healthcare quality. Furthermore, AI-driven objective decision support is expected to significantly reduce the risk of medication errors, enhancing medical safety. Consequently, overall hospital operational efficiency could improve, simultaneously achieving hundreds of thousands of dollars in annual cost savings and improved patient outcomes (AI est.).
Patent Record
APPLICATION NO.
特願2020-568194
REGISTRATION NO.
7412009
FILING DATE
2020/01/23
GRANT DATE
2023/12/28
EXPIRATION DATE
2040/01/23
PATENT HOLDER
国立研究開発法人科学技術振興機構
Examination History
2022年11月28日
手続補正書（自発・内容）
2022年11月28日
出願審査請求書
2023年11月21日
特許査定